Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model.

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{9902e113d99f40dbbd013eecb576790b,

title = "Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model.",

author = "\{van de Ven\}, S.M.W.Y. and S.G. Elias and C.T. Chan and Z. Miao and A. De and S.S. Gambhir",

year = "2012",

language = "English",

volume = "18",

pages = "1073--1081",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "4",

}

TY - JOUR

T1 - Optical imaging with her2-targeted affibody molecules can monitor hsp90 treatment response in a breast cancer xenograft mouse model.

AU - van de Ven, S.M.W.Y.

AU - Elias, S.G.

AU - Chan, C.T.

AU - Miao, Z.

AU - De, A.

AU - Gambhir, S.S.

PY - 2012

Y1 - 2012

M3 - Article

SN - 1078-0432

VL - 18

SP - 1073

EP - 1081

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 4

ER -